Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
Total Current Liabilities
Arcturus Therapeutics Holdings Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Total Current Liabilities
$115.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
51%
|
CAGR 10-Years
43%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Current Liabilities
$41.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
24%
|
CAGR 10-Years
21%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Current Liabilities
$13B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Current Liabilities
$19.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Current Liabilities
$3.8B
|
CAGR 3-Years
25%
|
CAGR 5-Years
28%
|
CAGR 10-Years
26%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Current Liabilities
$3.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
19%
|
CAGR 10-Years
28%
|
See Also
What is Arcturus Therapeutics Holdings Inc's Total Current Liabilities?
Total Current Liabilities
115.4m
USD
Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Total Current Liabilities amounts to 115.4m USD.
What is Arcturus Therapeutics Holdings Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
43%
Over the last year, the Total Current Liabilities growth was 28%. The average annual Total Current Liabilities growth rates for Arcturus Therapeutics Holdings Inc have been 29% over the past three years , 51% over the past five years , and 43% over the past ten years .